AN UNBIASED VIEW OF PENTOBARBITAL SODIUM IN HUMANS

pentobarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Carefully. Coadministration of CYP3A4 inducers may perhaps minimize sufentanil ranges and efficacy, potentially precipitating withdrawal syndrome in people who've produced physical dependence to sufentanil. Discontinuation